[VSsupport]

<img alt="" height="1" width="1" />Neurocrine Biosciences Reports First Quarter 2010 ResultsPR-USA.net (press release)... affinity and selective antagonists for the CRF1 receptor that are currently in clinical development for mood disorders and irritable bowel syndrome. ...<nobr></nobr>

View the full article